Myris Therapeutics Form D (2026)
Myris Therapeutics reported $500,000 raised in an SEC Form D filed on 2026-10-14.
- Company
- Myris Therapeutics
- Round type
- Form D
- Date
- 2026-10-14
- Amount
- $500K
- Industry
- Biotechnology
- Location
- Pennsylvania
Summary
The SEC Form D for Myris Therapeutics, filed on 2026-10-14, reports $500,000 raised. It was listed in the Raise Track Update of 2026-10-15. Filing: https://www.sec.gov/Archives/edgar/data/1924725/000192472526000004/0001924725-26-000004-index.htm
This page is not indexed by search engines yet because the filing is its only source.
Investors
Sources
Last verified:
- https://www.sec.gov/Archives/edgar/data/1924725/000192472526000004/0001924725-26-000004-index.htm
Type: sec filing. Accessed 2026-10-15.
SEC Form D for Myris Therapeutics, Inc. EDGAR filing date 2026-10-14. Signed 2026-10-14. First sale 2026-09-01. Total amount sold $500,000 of an offering amount of $4,500,000. 4 investors already invested. Issuer address city is Sharpsburg, Pennsylvania. Jurisdiction of incorporation is Delaware. The form does not name those investors or a round type. Street addresses are not published. The form includes middle initials on Laura E. Benjamin, David N. Colaizzi, Barbara S. Fox and Mark A. Murcko. The page uses Laura Benjamin, David Colaizzi, Barbara Fox and Mark Murcko. - https://buttondown.com/raisetrack/archive/raise-track-update-2026-10-15/
Type: other verified public source. Accessed 2026-10-15.
Raise Track Update for 2026-10-15, Section 3 (SEC Form D filings). Lists Myris Therapeutics, state PENNSYLVANIA, industry Biotechnology, amount raised $500,000.